Sherwin-Williams Co (SHW)
Official siteBASIC MATERIALS • SPECIALTY CHEMICALS • NYSE
Market Cap: $84.53B
Last updated: Nov 17, 2026 at 11:06 AM ET
Sherwin-Williams Co (SHW) Earnings: Report Dates and Results
Sherwin-Williams (SHW) is expected to report earnings on Jan 27, 2027. In the quarter ended Sep 30, 2026, Sherwin-Williams reported EPS of $3.63, below the $3.65 estimate. It beat the EPS estimate in 6 of the last 8 quarters.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
SHW has an expected report date of Jan 27, 2027. Analysts' consensus for the quarter ending Dec 31, 2026 is 6.3% above the $2.23 reported for the quarter ended Dec 31, 2025.
SHW Earnings Call
The latest SHW earnings call transcript on file is labeled 2026Q3.
Read the 2026Q3 transcriptEarnings History
Of the 40 quarters below that had an estimate, SHW beat 27, missed 11 and matched 2. Revenue for the quarter ended Sep 30, 2026 was $6.86B, up 7.9% from $6.36B a year earlier.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported | Revenue |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | $3.63 | $3.65 | $3.48 - $3.78 | -0.55% | Miss | +1.1% | 24 | 0 up, 4 down | Oct 27, 2026 | $6.86B |
| Jun 30, 2026 | $3.70 | $3.56 | $3.35 - $3.68 | +3.93% | Beat | +9.5% | 19 | 2 up, 2 down | Jul 28, 2026 | $6.79B |
| Mar 31, 2026 | $2.35 | $2.27 | $2.15 - $2.51 | +3.52% | Beat | +4.4% | 21 | 3 up, 6 down | Apr 28, 2026 | $5.67B |
| Dec 31, 2025 | $2.23 | $2.16 | $2.10 - $2.28 | +3.24% | Beat | +6.7% | 22 | 1 up, 2 down | Jan 29, 2026 | $5.60B |
| Sep 30, 2025 | $3.59 | $3.44 | $3.31 - $3.55 | +4.36% | Beat | +6.5% | 22 | 0 up, 9 down | Oct 28, 2025 | $6.36B |
| Jun 30, 2025 | $3.38 | $3.81 | $3.62 - $3.96 | -11.29% | Miss | -8.6% | 23 | 1 up, 2 down | Jul 22, 2025 | $6.31B |
| Mar 31, 2025 | $2.25 | $2.16 | $2.00 - $2.30 | +4.17% | Beat | +3.7% | 21 | 2 up, 10 down | Apr 29, 2025 | $5.31B |
| Dec 31, 2024 | $2.09 | $2.06 | $1.95 - $2.17 | +1.46% | Beat | +15.5% | 23 | 0 up, 7 down | Jan 30, 2025 | $5.30B |
| Sep 30, 2024 | $3.37 | $3.54 | $3.33 - $3.87 | -4.80% | Miss | +5.3% | 22 | 4 up, 1 down | Oct 22, 2024 | $6.16B |
| Jun 30, 2024 | $3.70 | $3.49 | $3.30 - $3.70 | +6.02% | Beat | +12.5% | 21 | 0 up, 0 down | Jul 23, 2024 | $6.27B |
| Mar 31, 2024 | $2.17 | $2.22 | $1.88 - $2.47 | -2.25% | Miss | +6.4% | 21 | 5 up, 0 down | Apr 23, 2024 | $5.37B |
| Dec 31, 2023 | $1.81 | $1.80 | $1.63 - $2.01 | +0.56% | Beat | -4.2% | 22 | 3 up, 0 down | Jan 25, 2024 | $5.25B |
| Sep 30, 2023 | $3.20 | $2.78 | $2.46 - $3.04 | +15.11% | Beat | +13.1% | 22 | 4 up, 1 down | Oct 24, 2023 | $6.12B |
| Jun 30, 2023 | $3.29 | $2.69 | $2.53 - $2.87 | +22.30% | Beat | +36.5% | 24 | 6 up, 0 down | Jul 25, 2023 | $6.24B |
| Mar 31, 2023 | $2.04 | $1.79 | $1.52 - $2.07 | +13.97% | Beat | +26.7% | 23 | 3 up, 1 down | Apr 25, 2023 | $5.44B |
| Dec 31, 2022 | $1.89 | $1.85 | $1.65 - $2.13 | +2.16% | Beat | +41.0% | 24 | 3 up, 1 down | Jan 26, 2023 | $5.23B |
| Sep 30, 2022 | $2.83 | $2.57 | $2.40 - $2.74 | +10.12% | Beat | +35.4% | 24 | 2 up, 1 down | Oct 25, 2022 | $6.05B |
| Jun 30, 2022 | $2.41 | $2.74 | $2.50 - $2.93 | -12.04% | Miss | -9.1% | 22 | 1 up, 2 down | Jul 27, 2022 | $5.87B |
| Mar 31, 2022 | $1.61 | $1.53 | $1.43 - $1.72 | +5.23% | Beat | -21.8% | 21 | 3 up, 1 down | Apr 26, 2022 | $5.00B |
| Dec 31, 2021 | $1.34 | $1.35 | $1.34 - $1.69 | -0.74% | Miss | -21.2% | 23 | 0 up, 6 down | Jan 27, 2022 | $4.76B |
| Sep 30, 2021 | $2.09 | $2.05 | N/A | +1.95% | Beat | -24.3% | 22 | 0 up, 15 down | Oct 26, 2021 | $5.15B |
| Jun 30, 2021 | $2.65 | $2.67 | $2.47 - $2.84 | -0.75% | Miss | +11.8% | 22 | N/A | Jul 27, 2021 | $5.38B |
| Mar 31, 2021 | $2.06 | $1.65 | $1.57 - $1.75 | +24.85% | Beat | +51.5% | 21 | N/A | Apr 27, 2021 | $4.66B |
| Dec 31, 2020 | $1.70 | $1.62 | $1.53 - $1.73 | +4.94% | Beat | +19.7% | 22 | N/A | Jan 28, 2021 | $4.49B |
| Sep 30, 2020 | $2.76 | $2.60 | $2.35 - $2.69 | +6.15% | Beat | +24.3% | 23 | N/A | Oct 27, 2020 | $5.12B |
| Jun 30, 2020 | $2.37 | $1.90 | $1.74 - $2.39 | +24.74% | Beat | +8.2% | 23 | N/A | Jul 28, 2020 | $4.60B |
| Mar 31, 2020 | $1.36 | $1.30 | $1.20 - $1.48 | +4.62% | Beat | +13.3% | 22 | N/A | Apr 29, 2020 | $4.15B |
| Dec 31, 2019 | $1.42 | $1.46 | $1.41 - $1.50 | -2.74% | Miss | +20.3% | 21 | N/A | Jan 30, 2020 | $4.11B |
| Sep 30, 2019 | $2.22 | $2.17 | $2.01 - $2.29 | +2.30% | Beat | +17.5% | 22 | N/A | Oct 22, 2019 | $4.87B |
| Jun 30, 2019 | $2.19 | $2.12 | $2.02 - $2.22 | +3.30% | Beat | +14.7% | 23 | N/A | Jul 23, 2019 | $4.88B |
| Mar 31, 2019 | $1.20 | $1.22 | $1.12 - $1.33 | -1.64% | Miss | +0.8% | 22 | N/A | Apr 23, 2019 | $4.04B |
| Dec 31, 2018 | $1.18 | $1.18 | $1.18 - $1.41 | 0.00% | In line | +12.4% | 24 | N/A | Jan 31, 2019 | $4.06B |
| Sep 30, 2018 | $1.89 | $1.92 | $1.81 - $2.00 | -1.56% | Miss | +19.6% | 24 | N/A | Oct 25, 2018 | $4.73B |
| Jun 30, 2018 | $1.91 | $1.88 | $1.75 - $2.00 | +1.60% | Beat | +26.5% | 24 | N/A | Jul 24, 2018 | $4.77B |
| Mar 31, 2018 | $1.19 | $1.05 | $0.93 - $1.27 | +13.33% | Beat | +56.6% | 23 | N/A | Apr 24, 2018 | $3.97B |
| Dec 31, 2017 | $1.05 | $1.05 | $0.86 - $1.13 | 0.00% | In line | +34.6% | 23 | N/A | Jan 25, 2018 | $3.98B |
| Sep 30, 2017 | $1.58 | $1.56 | $1.51 - $1.62 | +1.28% | Beat | +12.1% | 19 | N/A | Oct 24, 2017 | $4.51B |
| Jun 30, 2017 | $1.51 | $1.52 | $1.44 - $1.58 | -0.66% | Miss | +11.9% | 13 | N/A | Jul 20, 2017 | $3.74B |
| Mar 31, 2017 | $0.76 | $0.69 | N/A | +10.14% | Beat | +26.7% | N/A | N/A | Apr 20, 2017 | $2.76B |
| Dec 31, 2016 | $0.78 | $0.73 | N/A | +6.85% | Beat | +9.9% | N/A | N/A | Jan 26, 2017 | $2.78B |
Annual EPS
EPS for the fiscal year ended Dec 31, 2025 was $11.45, up 1.1% from the year before. It was $4.14 for the year ended Dec 31, 2016, the oldest of the 10 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Dec 31, 2025 | $11.45 | +1.1% |
| Dec 31, 2024 | $11.33 | +9.6% |
| Dec 31, 2023 | $10.34 | +18.3% |
| Dec 31, 2022 | $8.74 | +7.4% |
| Dec 31, 2021 | $8.14 | -0.6% |
| Dec 31, 2020 | $8.19 | +16.5% |
| Dec 31, 2019 | $7.03 | +13.9% |
| Dec 31, 2018 | $6.17 | +25.9% |
| Dec 31, 2017 | $4.90 | +18.4% |
| Dec 31, 2016 | $4.14 | N/A |
Earnings Calls
The 8 most recent earnings calls are listed below; the latest, 2026Q3 for the period ended Sep 30, 2026, runs about 9,500 words across 25 speakers.
| Call | Period ending | Words | Speakers | Transcript |
|---|---|---|---|---|
| 2026Q3 | Sep 30, 2026 | 9,497 | 25 | |
| 2026Q2 | Jun 30, 2026 | 6,061 | 22 | |
| 2026Q1 | Mar 31, 2026 | 9,342 | 21 | |
| 2025Q4 | Dec 31, 2025 | 9,310 | 24 | |
| 2025Q3 | Sep 30, 2025 | 8,385 | 25 | |
| 2025Q2 | Jun 30, 2025 | 10,379 | 25 | |
| 2025Q1 | Mar 31, 2025 | 8,660 | 27 | |
| 2024Q4 | Dec 31, 2024 | 9,306 | 24 |
2026Q3 Earnings Call
Opening remarks
James R. Jaye Senior Vice President, Investor Relations and Communications Good morning to everyone, and thank you for joining our call. Sherwin-Williams continued to deliver strong top-line growth despite persistent softness in demand across our end markets. Our above-market performance reflects continued execution of our strategy, new-account and share-of-wallet wins, and a clear return on prior growth investments. Consolidated sales grew by a high single-digit percentage, inclusive of mid-single-digit price/mix and low-single-digit contributions from acquisitions and volume. We have grown consolidated volume every quarter this year. Sales in the quarter grew at or above our guidance in all three segments. As we talked about at our Investor Day last month, our strong top-line growth will be a key driver of robust earnings growth and incremental margins as the inflationary cycle ultimately moderates. Reported gross margin in the quarter was primarily impacted by higher raw material and supply-chain-related costs, dilution from the Suvinil acquisition, and higher growth in lower-margin reportable segments. Gross margin is flat year to date, excluding the dilutive impact of Suvinil. Reported SG&A expense increased by a mid-single-digit percentage but decreased 50 basis points as a percent of sales. The increase was driven primarily by incremental costs related to the Suvinil acquisition and higher employee service costs to support higher-than-expected year-over-year sales. We continue to expect full-year reported SG&A to increase by a mid-single-digit percentage, including a low-single-digit contribution from Suvinil. Adjusted diluted net income per share increased by approximately 1%. EBITDA increased 3.4%, while adjusted EBITDA grew 3.3% to $1.4 billion, and adjusted EBITDA margin of 20.5% remained within our targeted range. Net operating cash decreased in the quarter and has grown 10%, or $232 million, year to date, driven by higher year-to-date net income and lower year-to-date use of cash for working capital. We returned $749 million to shareholders in the quarter and $3 billion year to date through share repurchases and dividends. Our balance sheet remains strong, and we ended the third quarter with a net debt-to-adjusted EBITDA ratio of 2.4 times. Let me now turn it over to Heidi, who will provide some color on third-quarter segment performance before moving on to our outlook and your questions.
Heidi G. Petz Chair, President, and Chief Executive Officer Thank you, Jim. I want to start by thanking our more than 64,000 employees around the world. Their hard work, dedication, and commitment to taking care of our customers continue to set Sherwin-Williams apart. Even in a challenging environment, our teams are finding new ways to win, grow with customers, and outperform the market. Our third-quarter sales performance reflects the strength of our strategy and the value customers are placing on our products and services. We continued to generate strong new-account growth, deepen relationships with existing customers, and gain meaningful share across the business.
Frequently Asked Questions About SHW
When is Sherwin-Williams's next earnings date?
Sherwin-Williams's next earnings report is expected for Jan 27, 2027.
Did SHW beat earnings estimates last quarter?
No. Sherwin-Williams reported EPS of $3.63 for the quarter ended Sep 30, 2026, below the $3.65 estimate by 0.55%.
What EPS do analysts expect from SHW next quarter?
The consensus EPS estimate for Sherwin-Williams for the quarter ending Dec 31, 2026 is $2.37 from 26 analysts, with estimates from $2.21 to $2.55.
How often does SHW beat earnings estimates?
Sherwin-Williams beat the EPS estimate in 6 of the last 8 quarters, with an average surprise of +1.11%.
SHW pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors